A problem that is affecting all the sectors throughout the
world is the problem of counterfeiting. Many products are forged and sold as
original to save on costs and earn better profits. It is being reported that
somewhere between 5% and 7% of all world trade belongs to counterfeited
products. The industry where counterfeit becomes all the more a big problem is
pharmaceuticals. Bilcare Technologies believes that medical industry is a very
sensitive one as it affects the lives of people. Counterfeiting in this
industry, hence, becomes a much bigger problem.
Counterfeiting has affected the global scenario of trade.
They damage the reputation of brand owners and puts consumers in a more
vulnerable position. It can also seriously affect the health and safety of the
consumers and can substantially reduce the profits of the legitimate players in
the market.
Bilcare fully understands the criticality of the situation
and thus, it has offered a full-proof end-to-end solution which is called t he
nonClonableID™ technology.
nonClonableID™ technology by Bilcare uses a material matrix
which encodes uniquely to each tag. These unique codes are prohibitively
difficult for counterfeiters to make a duplicate of. This solution by Bilcare
further ensures the safety of consumers by enabling a secure Track-n-Trace.
This leads to e-Pedigree through the supply chain.
Bilcare establishes total accountability through the secure
supply chain. The chain establishes Brand Security as its first step which
further leads to Product Integrity. Product Integrity is followed by
Traceability which further leads to e-Pedigree.
Such a full-proof secure system by Bilcare is commendable
and works well to ensure the safety of consumers. Bilcare has always given
preference to the health of its clientele above all other considerations and
its thoughtful concept of a nonClonableID™ exemplifies its concern.
No comments:
Post a Comment